Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Rita Fernanda Cortez de AlmeidaDepartment of Dermatology, Bonsucesso Federal Hospital, Rio de Janeiro, Brazil.ORCID 0000-0001-7904-998X
Roberta Espírito Santo CorreiaEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0003-0590-3201
Andréa Gina VarónEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0002-7542-2780
Janice Mery Chicarino de Oliveira CoelhoEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Ana Paola de OliveiraEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Maria Cristina Silva LourençoEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0003-0382-9108
Erica Aparecida Dos Santos Ribeiro da SilvaEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0003-3878-5918
Emilyn Costa ConceiçãoEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0002-7445-6620
Cristiane da Cruz LamasEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0002-5561-999X
Dayvison Francis Saraiva FreitasEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0003-2039-2438
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
Immunocompromised HostAdultAnti-Bacterial AgentsAntineoplastic AgentsHumansLymphomaMaleMycetomaNocardiaTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsAntineoplastic AgentsTrimethoprim, Sulfamethoxazole Drug Combination
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Actinomycetoma with systemic features: A warning sign for immunosuppression? · full record | OpenQuestion